Impact of PET/CT system, reconstruction protocol, data analysis method, and repositioning on PET/CT precision: An experimental evaluation using an oncology and brain phantom
暂无分享,去创建一个
Martin A. Lodge | Ronald Boellaard | Elisabeth Pfaehler | Maqsood Yaqub | R. Boellaard | M. Yaqub | M. Lodge | E. Pfaehler | S. Mansor | D. Heijtel | Syahir Mansor | Dennis Heijtel
[1] A. Lammertsma,et al. Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-d-glucose and positron emission tomography: an overview of different analytical methods , 2000, European Journal of Nuclear Medicine.
[2] Y. Koyama,et al. FDG-PET for preoperative differential diagnosis between benign and malignant soft tissue masses , 2003, Skeletal Radiology.
[3] Johan Nuyts,et al. Methods to monitor response to chemotherapy in non-small cell lung cancer with 18F-FDG PET. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] R. Boellaard. Standards for PET Image Acquisition and Quantitative Data Analysis , 2009, Journal of Nuclear Medicine.
[5] Drew A. Torigian,et al. Repeatability of 18F-FDG PET/CT in Advanced Non–Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials , 2015, The Journal of Nuclear Medicine.
[6] M. Schwaiger,et al. Comparison of different SUV-based methods for monitoring cytotoxic therapy with FDG PET , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[7] R. Boellaard,et al. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] Eric J. W. Visser,et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[9] R. Boellaard,et al. Repeatability of 18F-FDG PET in a Multicenter Phase I Study of Patients with Advanced Gastrointestinal Malignancies , 2009, Journal of Nuclear Medicine.
[10] Akira Maebatake,et al. Influence of Statistical Fluctuation on Reproducibility and Accuracy of SUVmax and SUVpeak: A Phantom Study , 2015, The Journal of Nuclear Medicine Technology.
[11] Adriaan A. Lammertsma,et al. Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[12] W. Oyen,et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[13] J. Matthews,et al. Impact of point spread function modelling and time of flight on FDG uptake measurements in lung lesions using alternative filtering strategies , 2014, EJNMMI Physics.
[14] M. J. Fusselman,et al. Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18]fluoro-2-deoxy-D-glucose. , 1996, Radiology.
[15] Adriaan A. Lammertsma,et al. Measuring [18F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[16] Paul Kinahan,et al. Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures , 2013, European Journal of Nuclear Medicine and Molecular Imaging.
[18] Jason P Fine,et al. Influence of reconstruction iterations on 18F-FDG PET/CT standardized uptake values. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] J Aoki,et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. , 2001, Radiology.
[20] Paul Kinahan,et al. Instrumentation factors affecting variance and bias of quantifying tracer uptake with PET/CT. , 2010, Medical physics.
[21] Arman Rahmim,et al. Resolution modeling in PET imaging: Theory, practice, benefits, and pitfalls. , 2013, Medical physics.
[22] K F Hübner,et al. Differentiating benign from malignant lung lesions using "quantitative" parameters of FDG PET images. , 1996, Clinical nuclear medicine.
[23] R. Wahl,et al. From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors , 2009, Journal of Nuclear Medicine.
[24] Martin A Lodge,et al. Noise Considerations for PET Quantification Using Maximum and Peak Standardized Uptake Value , 2012, The Journal of Nuclear Medicine.
[25] Ronald Boellaard,et al. Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non–Small Cell Lung Cancer Patients , 2016, The Journal of Nuclear Medicine.